期刊文献+

困惑与忧思:医学的边界在何处 被引量:12

Puzzle and Worries:Where Is the Boundary of the Medicine
下载PDF
导出
摘要 现代医学将治未病的理想变成了现实。对疾病危险因素的控制,癌症前期病变的基因检测,ECT等高清晰度的影像技术对人体微细病变的勾画,以及生命的正常过程、个人和社交问题的医疗化,疾病诊断标准不停歇的放宽,使得健康与疾病的界线愈来愈模糊,医学进步到没有健康人了。区分生命正常过程与疾病的不同,明确医学的边界,避免医学对人体过度的破坏性的干预,杜绝对医疗资源的浪费,是当今医学迫需努力解决的课题。 Modern medicine makes the idea of treatment of pro-disease come true. The boundary between health and disease is increasingly blurred due to the control of disease risk factors, gene detection of precancerous lesions, ECT and other high-resolution imaging techniques outlined human body in micro-lesions, as well as the normal course of life, medicalization of personal and social problems and the broaden disease diagnostic criteria without a break. Hence, medicine has progressed in a stage of no one is healthy. Distinguishing the differences between normal life processes and disease, clearing the boundary of medicine, avoiding excessive damage intervention of medicine to human body and putting an end to the waste of medical resources are today's urgent efforts to address the issue of medicine.
作者 杜治政
出处 《医学与哲学(A)》 北大核心 2014年第8期14-19,共6页 Medicine & Philosophy:Humanistic & Social Medicine Edition
关键词 治未病 危险因素控制 医学边界 生命医学化 preventive treatment of disease, control of risk factors, boundary of the medicine, life medicalization
  • 相关文献

参考文献9

  • 1布莱克.无效的医疗[M].穆易,译.北京:北京师范大学出版社,2007:93.
  • 2佚名.科学家们试图重新控制癌症[N].参考消息,201308-01(7).
  • 3布雷希.发明疾病的人[M].张志成,译.台北:左岸文化,2009.
  • 4张鸿棋.颅内微小动脉瘤治不治[N].健康报,2014-03-25(8).
  • 5许心.肺部结节并非全是癌[N].健康报,2013-11-08(14).
  • 6胡德荣.糖尿病前期人群多达5亿并非耸人听闻[N].健康报,2013-09-05(1).
  • 7李源德.颠倒医学的另类思考[M].台北:左岸文化,2009:5.
  • 8佚名.衰老是一种疾病吗[N].参考消息,2010-05-21(7).
  • 9韩启德.对疾病危险因素控制和癌症筛检的考量[J].医学与哲学(A),2014,35(8):1-6. 被引量:19

二级参考文献20

  • 1l.aw M R,Wald N J. Risk factor thresholds: their existence under scrutiny[J]. BMJ,2002,324(7353) : 1570- 1576.
  • 2Diao D, Wright J M,Cundiff D K, et al. Pharrnacotherapy for mild hypertension[J/OL]. Coehrane Database of Systematic Reviews, 2012(8). (2012- 11 - 14) [2014- 07- 16]. DOI: 10. 1002/ 14651858. (1)006742. pub2.
  • 3Emerging Risk Factors Collaboration. Major lipids,apolipoproteins, and risk of wascular disease[J]. J AMA, 2009,302(18) : 1993- 2000,.
  • 4Downs J R,Clearfield M, Weis S. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study[J]. JAMA, 1998,279(20) : 1615 - 1622.
  • 5Andriole G L, Crawford E D, Grubb R 3rd, et al. Prostate cancer screening in the randomized prostate, lung, coloreetal, and ovarian cancer screening trial: mortality results after 13 years of follow-up [J]. J Natl Cancer Inst, 2012,104(2) :125- 132.
  • 6Schroder F H, Hugosson J, Roobot M J, et al. Screening and prostate- cancer mortality in a randomized European study[J]. New Eng J of Med, 2009,360 : 1320- 1328.
  • 7Manser R, Lethaby A, Irving L B, et al. Screening for lung cancer: review[J/OL]. Cochrane Database of Systematic Reviews, 2013 (6), (2013-06-21)[2014 -07- 16]. DOI: 10. 1002/14651858. CD001991. pub3.
  • 8The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. New Eng J of Med,2011,365 : 395- 409.
  • 9Miller A B, Wall C,Baines C J,et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial[J]. BMJ, 2014,348 :g366.
  • 10Welch H G,Black W C. Overdiagnosis in cancer[J]. J Natl Cancer Inst, 2010,102(9) : 605 - 613,.

共引文献21

同被引文献140

引证文献12

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部